1. Home
  2. NTRA vs MTZ Comparison

NTRA vs MTZ Comparison

Compare NTRA & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$204.80

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Logo MasTec Inc.

MTZ

MasTec Inc.

HOLD

Current Price

$337.58

Market Cap

24.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
MTZ
Founded
2003
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Water Sewer Pipeline Comm & Power Line Construction
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.0B
24.9B
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
NTRA
MTZ
Price
$204.80
$337.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
18
Target Price
$259.07
$297.59
AVG Volume (30 Days)
1.1M
896.2K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
0.65
146.12
EPS
N/A
5.07
Revenue
$210,939,000.00
$14,299,171,000.00
Revenue This Year
$18.16
$20.38
Revenue Next Year
$20.00
$10.02
P/E Ratio
N/A
$66.32
Revenue Growth
N/A
16.22
52 Week Low
$130.29
$104.40
52 Week High
$256.36
$341.40

Technical Indicators

Market Signals
Indicator
NTRA
MTZ
Relative Strength Index (RSI) 53.10 65.57
Support Level $194.03 $166.03
Resistance Level $251.09 N/A
Average True Range (ATR) 7.50 15.16
MACD 2.09 1.46
Stochastic Oscillator 80.56 92.26

Price Performance

Historical Comparison
NTRA
MTZ

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

Share on Social Networks: